Literature DB >> 10603631

ADA1/ADAp ratio in pleural tuberculosis: an excellent diagnostic parameter in pleural fluid.

E Pérez-Rodríguez1, I J Pérez Walton, J J Sanchez Hernández, E Pallarés, J Rubi, D Jimenez Castro, G Diaz Nuevo.   

Abstract

We analysed the efficacy of pleural adenosine deaminase (ADAp) and the ADA1/ADAp ratio in the diagnosis of pleural tuberculosis in 103 pleural effusions, 27 of which were tuberculosis (TB) and 76 other diagnoses (non-TB). Smears, cultures and pleural biopsies were carried out in all cases, and were used for final diagnosis. The diagnostic yield of the parameters under study were as follows: smears/cultures of mycobacteria in fluid 11.1%/33.3%; biopsy 33.3%/51.8% and tuberculosis granulomas 85.1%. The levels of ADAp and ADA1/ADAp ratio in TB and non-TB groups showed very significant differences (P < 0.00001); in the TB group: ADAp 54.7 +/- 23.5 IU and ADA1/ADAp 0.27 +/- 0.08; in the non-TB group: ADAp 18.3 +/- 43.2 IU and ADA1/ADAp 0.64 +/- 0.14. The assay established ADA levels in pleural fluid > or = 40 IU and an ADA1/ADAp ratio < or = 0.42 as cut-off levels to identify individuals in the TB group, with a sensitivity of 88.8%/100%, a specificity of 92%/98.6%, a positive predictive value (PPV) of 80%/96.4%, a negative predictive value (NPV) of 95.8%/100% and an accuracy of 91.2%/99.02%. The ADAp levels in 27 patients with TB, showed close correlation with the number of monocyte macrophages (P = 0.001), but not with the number of lymphocytes (P = n.s.). The ADA1/ADAp ratio overcomes the limitations of ADAp (false positives and negatives), and is the most useful parameter for diagnosis on account of a high diagnostic yield, low cost and speed of the assay for identifying a pleural tuberculosis diagnosis, when compared with traditional methods.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10603631     DOI: 10.1016/s0954-6111(99)90267-6

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

Review 1.  Tuberculous pleural effusions: advances and controversies.

Authors:  Morné J Vorster; Brian W Allwood; Andreas H Diacon; Coenraad F N Koegelenberg
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

2.  Role of Adenosine Deaminase Estimation in Differentiation of Tuberculous and Non-tuberculous Exudative Pleural Effusions.

Authors:  Bharat Kumar Gupta; Vinay Bharat; Debapriya Bandyopadhyay
Journal:  J Clin Med Res       Date:  2010-03-31

Review 3.  Tuberculous pleurisy: an update.

Authors:  Doosoo Jeon
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

4.  Expression of YKL-40 and MIP-1a proteins in exudates and transudates: biomarkers for differential diagnosis of pleural effusions? A pilot study.

Authors:  Tonia Adamidi; Nikolaos Soulitzis; Eirini Neofytou; Savvas Zannetos; Andreas Georgiou; Kleomenis Benidis; Alexis Papadopoulos; Nikolaos M Siafakas; Sophia E Schiza
Journal:  BMC Pulm Med       Date:  2015-12-01       Impact factor: 3.317

5.  Adenosine deaminase activity is a sensitive marker for the diagnosis of tuberculous pleuritis in patients with very low CD4 counts.

Authors:  Kamaldeen Baba; Anwar A Hoosen; Nina Langeland; Anne M Dyrhol-Riise
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

6.  Challenges in the development of an immunochromatographic interferon-gamma test for diagnosis of pleural tuberculosis.

Authors:  Claudia M Denkinger; Yatiraj Kalantri; Samuel G Schumacher; Joy S Michael; Deepa Shankar; Arvind Saxena; Natarajan Sriram; Thangakunam Balamugesh; Robert Luo; Nira R Pollock; Madhukar Pai; Devasahayam J Christopher
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.